ABSTRACT -A two-generation reproductive toxicity study was performed to evaluate the effects of diethyl phthalate on parental reproductive performance, including features of the endocrine system and development and growth of offspring at dietary dose levels of 0, 600, 3000 and 15000 ppm. In F0 and F1 parents, no treatment-related adverse effects were observed in clinical findings, body weights, food consumption, reproductive parameters, and gross or histopathological findings in any treated group. Increased liver weights and enhanced activities of metabolic enzymes were observed in F0 males at 15000 ppm. F0 males also exhibited an increase in the content of CYP3A2, a cytochrome P450 isozyme, at 15000 ppm, and a decrease in the levels of serum testosterone at 3000 and 15000 ppm, suggesting sex steroid metabolism might be changed. However, these were not considered adverse effects because the degree of change was too slight to affect the reproductive capability to produce progeny. Body weight gains before weaning were inhibited in F1 and F2 pups and vaginal opening was slightly delayed in F1 females at 15000 ppm. No changes were observed in the reproductive performance. Therefore, the no-observed-adverse-effect level (NOAEL) from this study is considered to be 15000 ppm for parental animals, and 3000 ppm for development and growth of the pups.
INTRODUCTION
Diethyl phthalate (DEP), a plastic additive, has been used as a plasticizer for cellulose acetate, methacrylic acid, vinyl acetate and polystyrene, and as a solvent and a fixative for cosmetic products (Api, 2001) . Considering the fact that cellulose-based packaging materials may contain up to 20% DEP, possible human exposure has broad implications in the food and pharmaceutical industries. Phthalate esters are fairly stable and remain for long time in the environment, for example in soil and underground waters (Kamrin and Mayor, 1991) . It has been reported that DEP does not have any affinity for the estrogen receptor (Blair et al., 2000) , but a recombinant yeast screen and a test for mitogenic effects on estrogen-responsive human breast cancer cells indicated weak estrogenic activity (Harris et al., 1997) . Antiandrogenic effects have been reported for other phthalate esters such as butyl benzyl phthalate (BBP), di(2-ethylhexyl) phthalate (DEHP) and di-nbutyl phthalate (DBP), which are therefore suspected to be endocrine disruptors (Ema and Miyawaki, 2002; Gray et al., 2000; Lee et al., 2004; Moore et al., 2001; Tyl et al., 2004; Zhang et al., 2004) . However, whether or not DEP exerts any endocrine disrupting effects in vivo has hitherto been unclear.
Several reports on reproductive and developmental effects of DEP have been published and the standard continuous breeding design showed no apparent effect on reproductive function in Swiss CD-1 mice given diets with DEP at a dose level of 0, 0.25, 1.25 or 2.5% (Lamb et al., 1987) . An increased incidence of fetuses with skeletal defects was observed in rats administered DEP (0.338-1.125 mL/kg) by intraperitoneal injections on days 5, 10 and 15 of gestation (Singh et al., 1972) . It is also reported that supernumerary ribs (a skeletal vari-ation) in fetuses was induced following dietary administration to maternal rats on days 6 through 15 of gestation at a dose level of 5% DEP (Field et al., 1993) . No maternal or developmental toxicity was found after oral administration of DEP to the dam at 750 mg/kg from gestation day 14 to postnatal day 3 (Gray et al., 2000) . However, we are unaware of any previous study in which the reproductive and developmental effects of DEP were assessed comprehensively.
The present investigation was therefore conducted in rats given DEP over two-generations to evaluate the potential toxic effects of DEP on parental reproductive performance, with assessment of the endocrine system and development and growth of their offspring. Influence on sex steroid metabolism was investigated and determination of reproductive and developmental endpoints, such as sexual development, estrous cyclicity, anogenital distance, physical and functional development, and sperm count and motility, was included.
MATERIALS AND METHODS
This study was performed in compliance with a regulatory guideline (OECD, 2001 ) and in accordance with the principles for Good Laboratory Practice (Chemical Substance Control Law of EA, MHW and MITI, 1988) .
Chemical and dosing
The DEP (CAS # 84-66-2) used in this study was commercial grade (lot # SEM5441; Wako Pure Chemical Industries, Ltd., Tokyo, Japan) and the purity was 99.8%. Dose levels were selected based on the results of a preliminary reproduction study in rats. In the preliminary study, Crj:CD (SD) IGS rats (as F0 parental animals at 8 weeks of age), 8/sex/group, were given diets containing the test substance at dose levels of 0 (basal diet, control), 5000, 10000, 20000 or 40000 ppm for 4 weeks prior to mating and throughout the subsequent breeding period until weaning of F1 pups at 3 weeks of age. Clinical observation of parental animals revealed hematuria in 2 males at 20000 ppm and in 1 each of both sexes at 40000 ppm. Body weights of males and females were decreased throughout the experimental period at 40000 ppm. Relative liver weights were significantly increased in males at doses of 10000 ppm or more and absolute prostate weights were decreased at 20000 and 40000 ppm. Regarding the reproductive performance of parental animals, gestation length at 40000 ppm was reduced. Body weight gains of F1 pups were inhibited throughout the lactation period at 20000 and 40000 ppm and viability indices of F1 pups on lactation days 4 and 21 at 40000 ppm were remarkably decreased. Liver weights of male weanlings were decreased in all DEP-treated groups. Based on these results, 15000 ppm was selected for the high dose level in the present study because certain toxic effects on growth of the offspring would be expected. Then, the dose levels of 3000 and 600 ppm were selected for middle dose and low dose groups, respectively, dividing by a common ratio of 5.
The test substance was administered to animals orally by incorporation into the basal feed (NIH-07M, Clea Japan, Inc., Tokyo, Japan) at prescribed concentrations. Animals of the control and treated groups were given freely the basal feed and test diets, respectively, throughout the experiment. The test diets prepared were analyzed for the concentration of DEP and used to feed animals within 44 days after preparation, for which period stability of DEP in the test diets was confirmed by a previously performed analysis. The dietary route of administration is the most probable exposure route for this test substance in humans. DEP intake in F0 and F1 parental males and females was calculated during the treatment period for males and the pre-mating, gestation and lactation periods, except for lactation days 14 to 21 for females, on a weekly basis from the group means of body weight and food consumption of each week, and data are shown in Table 1 .
Animals and housing conditions
Specific pathogen free Crj:CD (SD) IGS rats were used in this study. This strain of rats was chosen because it is the most commonly used for this type of study and historical control data are available. A hundred and fourteen animals of each sex were purchased from Tsukuba Breeding Center, Charles River Japan, Inc. at 4 weeks of age.
Animals were maintained in a barrier-sustained animal room with a controlled temperature (23 ± 3°C), humidity (50% ± 20%), ventilation (10 to 15 times per hr), and lighting cycle (12 hr artificial light, 8:00 to 20:00; 12 hr dark) and were given local tap water ad libitum. Rats were housed individually, except for during the acclimation (one or two animals by sex), mating (one male and one female) and lactation periods (one litter), in metallic bracket-type cages with wire mesh floors. From gestation day 17 to lactation day 21 (the day of weaning), individual dams and litters were Vol. 30 Special Issue reared on bedding (Whiteflake, Charles River Japan, Inc., Yokohama, Japan).
After the one week quarantine and acclimatization period, 96 healthy animals of each sex were selected at 5 weeks of age for use. The animals were weighed and assigned to 4 groups in such a way to equalize group means and standard deviations of body weights. Each group consisted of 24 males and 24 females, as F0 parental animals. All were assigned a unique number and ear tattooed, prior to initiation of the administration period.
Experimental design and mating procedures
The F0 animals were first fed for 10 weeks (premating period). Daily observation of vaginal smears was initiated at treatment week 9 and mating of animals was initiated at treatment week 11. From the initial day of the mating period, each female was continuously housed with a male in the same test group on a 1:1 basis, in the male's cage, until the day of successful copulation. Every morning, the females were examined for vaginal plugs and sperm in vaginal smears. The date of detection of vaginal plugs and/or sperm was defined as gestation day 0 (GD 0). These procedures were repeated within the 3-week mating period until pregnancy resulted.
The day on which parturition was completed was designated as postnatal day 0 (PND 0). On PND 4, pups were selected by sex at random so that the number of pups in a litter was 8 (if possible, 4 males and 4 females), and the remaining pups were euthanized and autopsied. Weaning of pups was performed on PND 21.
In each group, 24 males and 24 females were selected from F1 weanlings at 21 to 25 days of age to become F1 parental animals. The selection of F1 weanlings was performed from litters born during a 5-day period including the day of the largest number of parturitions among all the groups. The number of weanlings selected from each litter was 1 or 2 per sex and the mean body weights were equalized among groups as much as possible.
F1 parental animals were reared for 10 weeks and bred to obtain F2 offspring in the same manner as described for F0 parental animals. Sibling matings were not performed.
The total length of administration to both F0 and F1 parental animals was approximately 15 weeks for males and approximately 17 weeks for females.
Parental data
Each animal was examined twice daily for clinical signs and mortality throughout the experimental period. Body weights and food consumption were recorded weekly in both sexes before mating. In females after copulation, body weights and food consumption of dams were recorded on GDs 0, 7, 14 and 20 and PNDs 0, 7, 14 and 21.
Reproductive performance
Only F1 animals were examined for sexual maturation. F1 males and females were observed daily for preputial separation from 35 days of age and for vaginal opening from 27 days of age to determine the day of completion. Body weights on the day at completion were determined.
Vaginal smears were taken from each F0 and F1 female, stained with Giemsa solution, and examined microscopically. The vaginal smears were checked for two weeks before and during the mating period, until DEP 15000 ppm DEP intake was calculated during the treatment period for males and the pre-mating, gestation and lactation periods, except for lactation days 14-21 for females, on a weekly basis from the group means of body weight and food consumption. evidence of copulation was found.
All F0 and F1 females that copulated were allowed to deliver naturally. They were observed for signs of parturition at least three times (at approximately 9:00, 13:00 and 17:00) daily from GDs 21 to 25. Females holding their pups under the abdomen to nurse them at 1:00 p.m. were considered to have completed parturition on that day. Cases where females had one or more live pups without any abnormalities such as dystocia were considered as normal deliveries. The gestation length was represented as the number of days from detection of copulation (GD 0) to completion of parturition. Pregnancy was confirmed by the occurrence of parturition or by the presence of implantation sites in the uterine horns at autopsy. The number of implantation sites in the uterus was counted for each female at autopsy.
Litter data
All F1 and F2 pups were examined for clinical signs and mortality daily before weaning. For each litter delivered normally, each pup was sexed externally and the numbers of males, females and the total were recorded on PND 0. In each litter, pups were individually weighed on PNDs 0, 4, 7, 14 and 21. Anogenital distance (AGD) was measured using a caliper on PNDs 0 and 4 for all F1 and F2 pups. The number of pups surviving in each litter was counted on PNDs 0, 4 and 21 and viability indices were calculated.
Physical development and reflex ontogeny
All F1 and F2 pups were observed daily for pinna detachment on PNDs 1 to 4, incisor eruption from PND 8 to the day of completion, and eye opening from PND 12 to the day of completion. One male and one female of the F1 and F2 pups selected from each litter were evaluated daily for surface righting reflex from PND 4, negative geotaxis reflex from PND 7, and midair righting reflex from PND 13, each until the day of completion.
Sperm examination
Sperm parameters were determined in all F0 and F1 male adults, except for males found dead or killed during the study, on the day of the scheduled terminal sacrifice. The right cauda epididymis was weighed and used for sperm analysis. The right testis was also employed, for counting homogenization-resistant testicular spermatids. The cauda epididymis was placed in a petri dish containing 4 mL of medium (Medium 199, GIBUCO, Gland Island, NY, USA) supplemented with bovine serum albumin (0.5%) (Cohn Fraction V Powder, INTERGEN, NY, USA), cut into 6 pieces with a surgical knife, and incubated in a CO 2 incubator at 37°C and 5% CO 2 for 5 min. After incubation, 0.05 mL of the epididymal fluid was put into a 1.5 mL capillary tube containing 0.45 mL of the medium and incubated in the CO 2 incubator for 5 min to diffuse the sperm. Sperm motility was analyzed using a computerassisted cell motion analyzer (HTM-IVOS, Hamilton Thorne Research, Beverly, MA, USA) and the percentage of motile sperm and progressively motile sperm, as well as the swimming speed and pattern, were determined.
After recording sperm motion, cauda epididymal fluid was diluted and the sperm were enumerated using a hematocytometer under a light microscope. After being weighed, the tunica albuginea was removed from the testis and the parenchyma was homogenized in phosphate buffer solution (PBS), then sperm heads were also enumerated, again using a hematocytometer under a light microscope. Sperm counts were expressed as the number per cauda epididymis or testis and per gram cauda epididymis or testis. The sperm were stained with eosin and smeared on a slide glass and two hundred in each sample were examined under a light microscope, to determine the percentage which were morphologically abnormal.
Determination of cytochrome P450 isozyme contents in the liver
Six F0 parental males of each group were selected for the determination of cytochrome P450. Microsomal fractions of the liver were prepared and the total amount of microsomal protein was determined according to a modification of the methods of Lowry (Lowry et al., 1951 , Peterson, 1979 . The contents of cytochrome P450 isozymes (CYP1A1/2, CY P2B1 , C YP 3A2 and CY P4A 1) in the liver microsomes were determined by an immunochemical method using commercial primary antibodies (anti-rat polyclonal antibodies for each isozyme, Daiichi Pure Chemicals Co., Ltd., Tokai-mura, Japan). The analysis was performed at The Institute of Environmental Toxicology (Ibaraki, Japan).
Serum hormone levels
The levels of serum testosterone and progesterone in F0 males were determined to investigate the effects on metabolism of these steroid hormones in the same animals for which P450 isozyme contents were determined. At autopsy, blood samples were collected from the abdominal aorta of these rats. Total testosterone and progesterone levels were measured with radioimmunoassay kits (Japan DPC Co., Chiba, Japan) at Panapharm Laboratories Co., Ltd. (Kumamoto, Japan).
Termination/autopsy-parental animals
All F0 and F1 parental animals were euthanized by exsanguination under ether anesthesia and autopsied after weaning of their F1 and F2 offspring. The animals that failed to produce offspring were also euthanized by exsanguination under ether anesthesia and autopsied. Major organs were fixed and preserved in neutral, phosphate-buffered 10% formalin. The testes and epididymides were fixed with Bouin's solution and preserved in 70% ethanol.
Weights of the brain, liver, kidneys, spleen, pituitary gland, adrenal glands, testes, epididymides, prostate (ventral lobe), ovaries and uterus were recorded before fixation. Weights of the thyroid glands and seminal vesicles (with coagulating glands) were measured after fixation. For the bilateral organs, values were the sums of the weights for both sides.
Termination/autopsy-pups
F1 and F2 pups not selected on PND 4 were euthanized by inhalation of carbon dioxide and autopsied on that day. F1 weanlings not selected as F1 parental animals and all F2 weanlings were euthanized and autopsied according to the same methods as for the parental animals, at 26 days of age.
The same organs as the parental animals and the thymus of one pup per sex, which was selected at random from each litter of the F1 and F2 weanlings in each group, were weighed. The same organs and tissues as their parental animals were fixed and preserved.
Histopathological examination
In the control and high-dose groups, all F0 and F1 parental animals were examined histopathologically for abnormalities of the reproductive organs (i.e., ovaries, uterus, and vagina, or testes, epididymides, seminal vesicles, coagulating glands, and prostate), and of the pituitary gland, thyroid glands, liver, adrenal glands, and mammary glands. In the low dose group, histopathological examination of the same organs as the control and high-dose groups was also performed only for females that showed abnormal estrous cyclicity, males that showed sperm abnormality, and pairs of animals that failed to mate or produce offspring.
In addition, the kidneys of F1 parental female animals in the control and high-dose groups were examined histopathologically, because a significant increase in the organ weight was noted in F1 parental females of the high-dose group as compared with controls. In F1 and F2 weanlings, histopathological examination was performed for the thymus of six each of the F1 and F2 males and females, and for the spleen of six F2 males each in the control and 15000 ppm groups, because the thymus weights in both sexes of the F1 and F2 weanlings and the spleen weights of F2 male weanlings were significantly decreased at 15000 ppm as compared with the control values.
Statistical analyses
Body weights, body weight gain, food consumption, length of the estrous cycle, gestation length, numbers of implants and pups delivered, the delivery index, sperm parameters, P450 isozyme contents, hormone levels, organ weights, organ/body weight ratios (relative organ weights), age completed reflex responses, pinna detachment, incisor eruption and eye opening, age and body weights at sexual maturation, AGD, and viability of pups were analyzed for statistical significance in the following way: homogeneity of variance was evaluated first by Bartlett's test (p≤0.05). When group variances were homogeneous, the one-way analysis of variance (p≤0.10) was used to determine if any statistical differences existed among the groups. If the analysis of variance gave a significant result, Dunnett's test (p≤0.05 or 0.01) was performed to detect any significant differences between the treated groups and their corresponding controls. When Bartlett's test indicated that the variances were not homogeneous, the Kruskal-Wallis test (p≤0.10) was used for detecting any statistical differences and if they were significant, the Mann-Whitney U test (p≤0.05 or 0.01) was performed to detect any significant differences between the treated groups and their corresponding controls (Gad, 2001) . Statistical analyses were performed using the litter averages for body weights and the AGDs of pups per sex before weaning.
The Wilcoxon rank-sum test (p≤0.05 or 0.01) was employed to analyze the data on completion of physical development of pups using the litter as the unit for statistical evaluation (Gad, 2001) .
The incidences of females with normal estrous cyclicity, and indices of copulation, fertility and gestation, and sex ratios of pups were analyzed by the Chisquare test or Fisher's exact probability test (p≤0.05 or 0.01) (Gad, 2001) .
RESULT
Clinical observations, body weights and food consumption in F0 and F1 parental animals during the premating, mating, gestation and lactation periods There were no compound-related clinical signs of toxicity in either parental males or females in either generation during the premating, mating, gestation or lactation periods. One F0 male in the 3000 ppm group was euthanized because of a nasal bone fracture due to an accident in the cage. One F0 female died of dystocia and another F0 female was euthanized because of pyometra in the control group.
Body weight changes of F0 and F1 males and females during dosing are shown in Figs. 1 − 4. There were significantly increased body weights and body weight gain in F0 females during the premating period in the 600 ppm group and a significantly increased body weight gain at treatment week 0-1 in F1 males in the 15000 ppm group (the value was 51.5 g as against 45.8 g in the control group). With F0 females in the 15000 ppm group, body weight gain during lactation was significantly increased. These changes were not observed in F1 females. No significant differences were observed in any other treatment group.
Significant reduction of food consumption was observed from the end of the premating period to gestation period in F0 females in the 3000 ppm group. In the 15000 ppm group, there was a significant increase in both sexes of the F1 animals at treatment week 1, while no changes were observed in either sex of the F0 animals.
Reproductive performance in F0 and F1 parental animals
Data for estrous cyclicity in F0 and F1 females are shown in Table 2 . The incidences of females having normal estrous cycles and the estrous cycle length did not significantly differ in either generation between the control and DEP-treated groups.
Reproductive data for F0 and F1 parental animals are presented in Table 3 . In the F0 generation, one pair in the 600 ppm group did not copulate, one female each in the control, 600 and 15000 ppm groups did not become pregnant, and one female in the 15000 ppm group did not deliver. In the F1 parental animals, one pair in the 3000 ppm group did not copulate, and one female each in the control, 600, 3000 and 15000 ppm groups was not pregnant.
There were no significant differences in the copulation, fertility or gestation indices, numbers of implants, delivery index, or numbers of pups delivered between the control and DEP-treated groups. The gestation length was significantly shortened in F1 females in the 15000 ppm group by 0.3 days.
Clinical observations, sex ratio, viability indices, body weights and anogenital distance in F1 and F2 pups before weaning
No treatment-related adverse effects on clinical findings before weaning were observed in the F1 or F2 pups in any of the DEP-treated groups. Litter data on the sex ratio, viability indices, body weights and AGD in F1 and F2 offspring before weaning are shown in Table 4 . Significantly reduced body weights were observed in the 15000 ppm group on PND 4 through 21 for F1 female pups and on PND 21 for F1 and F2 male and F2 female pups. No treatment-related adverse effects were observed with regard to the sex ratio, viability index, or AGD of F1 or F2 pups before weaning in any of the DEP-treated groups.
Physical development and reflex ontogeny in F1 and F2 pups
Data on physical development in F1 and F2 pups are presented in Table 5 . There were no significant differences in the ages at completion of pinna detachment, incisor eruption or eye opening in the 600 and 3000 ppm groups as compared with the control group in either sex of the F1 and F2 pups. Retardation of pinna detachment or eye opening was observed in both sexes of the F1 and F2 pups in the 15000 ppm group, which appeared related to decrease in body weights in the lactation period.
In reflex response tests of F1 and F2 pups, no significant differences were observed in the ages at completion of the surface righting, negative geotaxis or mid-air righting reflexes between the control and DEPtreated groups in either sex (data not shown). Table 6 shows data for sperm parameters in F0 and F1 males. No significant differences in sperm counts or motility were observed in F0 and F1 males between the control and DEP-treated groups. Incidences of abnormal sperm and tailless sperm were significantly increased in F0 males in the 3000 ppm group and in F1 males in the 3000 and 15000 ppm groups. 22.1 ± 0.3* 22.3 ± 0.6 22.3 ± 0.5 22.4 ± 0.5 Gestation length (days) 14.7 ± 2.5 14.9 ± 2.7 14.3 ± 3.2 14.3 ± 2.5 No. of implantations 89.8 ± 17.9 91.8 ± 13.2 93.7 ± 8.4 91.3 ± 11.1 Delivery index (%)
Sperm parameters in F0 and F1 parental males

Sexual development in F1 male and female rats
13.3 ± 3.5 13.9 ± 3.1 13.5 ± 3.5 13.0 ± 2.8 No. of pups delivered a Mean ± SD. b Copulation index (%) = (No.of rats with successful copulation/no.of rats paired) ×100. 6.7 ± 0.7 7.0 ± 0.7 7.0 ± 0.6 6.9 ± 0.7 a Day 0 9.7 ± 1.4 10.5 ± 1.9 10.1 ± 1.4 10.6 ± 1.4 Day 4
15.3 ± 3.2 16.0 ± 3.8 15.6 ± 2.6 17.4 ± 2.4 Day 7 32.2 ± 4.8 f 33.4 ± 6.0 33.6 ± 3.3 35.6 ± 3.7 Day 14 48.1 ± 4.8 f ** 55.1 ± 9.5 56.8 ± 6.6 59.0 ± 7.7 Day 21 Female pup weight before weaning (g) 6.3 ± 0.6 6.5 ± 0.7 6.5 ± 0.7 6.5 ± 0.7 Day 0 9.1 ± 1.1* 9.9 ± 1.6 9.6 ± 1.5 10.2 ± 1. 6.8 ± 0.6 6.9 ± 0.7 7.0 ± 0.7 7.1 ± 0.5 Day 0 10.8 ± 1.6 10.7 ± 1.2 10.6 ± 1.5 11.4 ± 1.8 Day 4
17.8 ± 2.2 18.1 ± 1.5 17.5 ± 2.7 18.3 ± 3.0 Day 7 36.4 ± 3.5 36.8 ± 3.1 36.1 ± 3.9 36.5 ± 6.4 Day 14 53.8 ± 4.8** 60.6 ± 4.5 61.4 ± 6.9 60.9 ± 9.5 Day 21 Female pup weight before weaning (g) 6.3 ± 0.4 g 6.4 ± 0.5 f 6.5 ± 0.7 6.6 ± 0.6 Day 0 10.0 ± 1.1 g 10.0 ± 0.9 f 9.9 ± 1.4 10.8 ± 2.1 Day 4
16.7 ± 1.6 g 17.1 ± 1.7 f 16.8 ± 2.4 17.1 ± 3.7 Day 7 34.8 ± 2.7 g 35.7 ± 2.9 f 35.1 ± 3.9 35.1 ± 6.4 Day 14 51.5 ± 4.2 g ** 58.2 ± 4.2 f 58.7 ± 6.2 58.2 ± 9.4 Day 21 Anogenital distance (mm) 3.65 ± 0.24 3.64 ± 0.20 3.59 ± 0. age and body weights at completion of preputial separation in F1 males between the control and DEPtreated groups. On the other hand, the age at completion of vaginal opening was significantly delayed in F1 females in the 15000 ppm group as compared with the control group. There were no significant differences in the body weights at completion of vaginal opening in any of the DEP-treated groups.
Autopsy and histopathology in F0 and F1 parental animals
There were no treatment-related gross lesions at autopsy in F0 and F1 parental animals, including those that proved unable to produce their progeny, in any of the DEP-treated groups. There were no treatmentrelated abnormalities on histopathological examination of the reproductive organs, endocrine organs and liver in either sex of the F0 and F1 parental animals in the 15000 ppm group.
Organ weights in F0 and F1 parental animals
Organ weights in F0 and F1 parental animals are presented in Tables 8 and 9 . No significant differences in any organs were found in either sex of the F0 and F1 parental animals in the 600 and 3000 ppm groups, except for a significantly increased value for the thyroid glands in F1 males in the 3000 ppm group, with no dose-response relationship.
In the 15000 ppm group, absolute and/or relative liver weights in both sexes of the F0 and F1 parental animals were significantly increased. In addition, absolute adrenal gland and epididymis weights in F0 males were significantly decreased, with significantly low relative adrenal gland weights in F1 males and significantly high values for absolute and relative kidney weights in F1 females of this group.
P450 isozyme contents in F0 parental males
Data for P450 isozyme contents in livers of F0 3.0 ± 0.6* 2.5 ± 0.7 2.6 ± 0.6 2.5 ± 0.7 a Male 3.0 ± 0.6 2.5 ± 0.7 2.7 ± 0.7 2.5 ± 0.6 Female Age at incisor eruption (days) 11.2 ± 0.9* 11.5 ± 1.0 11.8 ± 0.9 11.9 ± 0.7 Male 11.2 ± 1.1 11.2 ± 1.0 11.3 ± 0.9 11.7 ± 0.7 Female Age at eye opening (days) 14.5 ± 0.7 14.4 ± 0.5 14.3 ± 0.6 14.3 ± 0.4 Male 14.5 ± 0.8 14.2 ± 0.6 14.1 ± 0.7 14.1 ± 0. 2.8 ± 0.6 2.6 ± 0.6 2.6 ± 0.7 2.4 ± 0.9 Male 2.9 ± 0.4 c 2.7 ± 0.5 b 2.6 ± 0.7 2.5 ± 0.8 Female Age at incisor eruption (days) 11.7 ± 0.9 11.8 ± 0.8 11.4 ± 1.1 11.4 ± 0.7 Male 11.5 ± 0.8 c 11.6 ± 0.6 b 11.6 ± 1.3 11.2 ± 0.8 Female Age at eye opening (days) 14.3 ± 0.6 14.3 ± 0.6 14.1 ± 0.7 14.2 ± 0.8 Male 14.1 ± 0.4 c 14.2 ± 0.6 b 14.0 ± 0.7 14.1 ± 0.9 Female a Mean ± SD. b and c Values obtained from 21 and 22 litters, respectively. * Significantly different from the control, p≤0.05. 
18.4 ± 0.9 19.3 ± 1.1 18.1 ± 4.0 18.6 ± 1.1 Mean lateral head displacement (µm)
28.2 ± 2.3 28.0 ± 1.5 29.0 ± 4.7 27.5 ± 1.5 Mean beat cross frequency (Hz) 64.9 ± 7.3 64.3 ± 9.7 64.6 ± 10.6 66.7 ± 5.1 Mean straightness (%) 27.7 ± 3.8 27.3 ± 4.0 27.8 ± 4.1 28.5 ± 2.6 Mean linearity (%) 0. 76.7 ± 10.1 75.2 ± 11.5 76.3 ± 12.2 76.2 ± 9.0 Progressive motility (%) 149 ± 9 151 ± 11 151 ± 10 150 ± 8 Mean path velocity (µm/sec) 103 ± 10 103 ± 10 104 ± 10 102 ± 9 Straight line average velocity (µm/sec) 348 ± 25 352 ± 31 354 ± 22 350 ± 25 Mean curvilinear velocity (µm/sec) 19.2 ± 0.6 19.5 ± 0.7 19.4 ± 0.9 19.6 ± 0.8 Mean lateral head displacement (µm) 27.2 ± 1.2 27.7 ± 1.7 27.4 ± 1.7 26.9 ± 1.5 Mean beat cross frequency (Hz) 68.6 ± 3.2 68.3 ± 3.2 69.1 ± 3.8 67.9 ± 3.4 Mean straightness (%) 29.6 ± 1.4 29.5 ± 1.4 29.7 ± 1.8 29.3 ± 1.7 Mean linearity (%)
1.52 ± 1.18** 1.31 ± 0.84** 0.83 ± 0.72 0.60 ± 0.53 Abnormal sperm rate (%)
1.40 ± 1.06** 1.25 ± 0.78** 0.75 ± 0.69 0.58 ± 0.48 Tailless sperm rate (%) a Mean ± SD. * Significantly different from the control, p≤0.05. ** Significantly different from the control, p≤0.01. 3.44 ± 0.23* 3.21 ± 0.28 3.13 ± 0.29 3.23 ± 0.24 3.52 ± 0.33 3.57 ± 0.34 3.59 ± 0.38 3.63 ± 0.37 Kidneys (g) 0.63 ± 0.05 0.61 ± 0.05 0.63 ± 0.06 0.62 ± 0.04 0.77 ± 0.12 0.84 ± 0.12 0.81 ± 0.10 0.82 ± 0.14 Spleen (g) 0.14 ± 0.02 0.14 ± 0.02 0.14 ± 0.02 0.14 ± 0.02 12.5 ± 1.7 13.9 ± 1.7 13.8 ± 1.9 13.1 ± 2.5 Pituitary gland (mg) 2.23 ± 0.32 2.37 ± 0.33 2.42 ± 0.39 2.24 ± 0.37 26.6 ± 6.5 28.2 ± 5.7 26.5 ± 4.9 27.0 ± 3.1 Thyroid glands (mg) 4.7 ± 1.0 4.8 ± 0.9 4.6 ± 0.7 4.6 ± 0.6 50 ± 8* 52 ± 8 54 ± 7 57 ± 9 Adrenal glands (mg) 8.9 ± 1.3 8.9 ± 1.2 9.5 ± 1.4 9.7 ± 1.4
3.38 ± 0.31 3.51 ± 0.23 3.38 ± 0.64 3.49 ± 0.33 Testes (g) 0.60 ± 0.06 0.60 ± 0.03 0.60 ± 0.14 0.60 ± 0.06 1.23 ± 0.11* 1.29 ± 0.08 1.23 ± 0.18 1.30 ± 0.13 Epididymides (g) 0.22 ± 0.03 0.22 ± 0.02 0.22 ± 0.04 0. 0.86 ± 0.14 0.85 ± 0.16 0.82 ± 0.15 0.84 ± 0.12 Spleen (g) 0.14 ± 0.02 0.14 ± 0.02 0.14 ± 0.02 0.14 ± 0.02 13.2 ± 1.6 13.6 ± 1.9 13.5 ± 1.7 13.7 ± 1.9 Pituitary gland (mg) 2.15 ± 0.22 2.22 ± 0.33 2.25 ± 0.29 2.27 ± 0.33 26.9 ± 5.1 29.8 ± 5.4** 27.0 ± 5.0 25.3 ± 5.2 Thyroid glands (mg) 4.4 ± 0.9 4.9 ± 1.0* 4.5 ± 0.9 4.2 ± 0.8 57 ± 6 57 ± 8 60 ± 9 61 ± 6 Adrenal glands (mg) 9.2 ± 0.9* 9.3 ± 1.4 10.0 ± 1.3 10.0 ± 0.9 3.59 ± 0.31 3.63 ± 0.32 3.61 ± 0.42 3.65 ± 0. parental males are shown in Table 10 . No significant differences were observed in the contents of CYP1A1/ 2 and CYP2B1 in the DEP-treated groups as compared with the control group. Significant increases in the contents of CYP4A1 and CYP3A2 were observed limited to the 15000 ppm group.
Serum hormone levels in F0 parental males
The levels of serum testosterone and progesterone in F0 parental males are shown in Table 11 . No significant differences in the levels of serum progesterone in F0 males were noted between the control and DEPtreated groups. Significant decreases were observed in the levels of serum testosterone in the 3000 and 15000 ppm groups.
Autopsy and histopathology findings for F1 and F2 pups
On gross pathological examination of pups that died before weaning or were euthanized on PNDs 4 and 26, there were no treatment-related abnormalities in either F1 or F2 generation. No abnormalities attributable to DEP-treatment were found on histopathological examination of the thymus and spleen in the 15000 ppm group.
Organ weights in F1 and F2 weanlings
The organ weights for male and female F1 and F2 weanlings are presented in Tables 12 and 13. In the 600 ppm group, no significant changes were observed except for a reduction of relative liver weights in F1 males. This change was considered incidental because of the lack of any dose-response relationship. In the 3000 ppm group, absolute adrenal gland weights in F1 females and relative uterine weights in F2 females were significantly decreased. These changes were also observed in the 15000 ppm group. In the 15000 ppm group, relative liver weights were significantly increased in both sexes of the F1 and F2 weanlings. In this group, absolute and relative thymus weights in both sexes of the F1 and F2 weanlings, absolute spleen weights in F1 males, and absolute and relative spleen weights in F2 males were significantly decreased. However, no histopathological abnormalities were observed in these organs. In addition, significant decreases were observed in absolute adrenal gland weights in both sexes of the F1 and F2 weanlings, in absolute prostate weights in F1 males, in absolute uterine weights in F1 females, and in absolute and relative uterine weights in F2 females in the 15000 ppm group. Changes in weights of the brain, kidneys, thyroid Table 10 . Hepatic microsomal cytochrome P450 isozyme contents in F0 parental males. Table 11 . Serum hormone levels in F0 parental males. DEP (ppm) 15000 3000 600 0 (control) 6 6 6 6 No. of F0 parental males examined 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 a CYP1A1 (p mol/mg protein)
1.23 ± 1.28 2.31 ± 1.17 2.62 ± 1.76 2.37 ± 1.81 CYP1A2 (p mol/mg protein) 17.8 ± 3.1 13.4 ± 4.9 19.7 ± 3.0 15.7 ± 5.7 CYP2B1 (p mol/mg protein) 92.0 ± 15.4** 33.2 ± 13.1 62.2 ± 18.5 55.6 ± 20.5 CYP3A2 (p mol/mg protein) 62.8 ± 19.2* 11.5 ± 2.6 15.0 ± 6.9 13.7 ± 3.1 CYP4A1 (p mol/mg protein) a Mean ± SD. * Significantly different from the control, p≤0.05. ** Significantly different from the control, p≤0.01. DEP (ppm) 15000 3000 600 0 (control) 6 6 6 6 No. of F0 parental males examined 1.26 ± 0.66* 0.50 ± 0.26** 1.81 ± 0.46 2.53 ± 1.23 a Testosterone (ng/mL) 3.08 ± 0.94 5.98 ± 3.00 3.61 ± 2.50 2.66 ± 2.51 Progesterone (ng/mL) a Mean ± SD. * Significantly different from the control, p≤0.05. ** Significantly different from the control, p≤0.01. glands, pituitary gland and seminal vesicles in F1 and F2 weanlings were also observed.
DISCUSSION
A two-generation reproductive toxicity study was here performed to evaluate the potential effects of DEP on the reproduction and development. Male and female Crj:CD (SD) IGS rats received a diet containing 0, 600, 3000 or 15000 ppm of DEP (approximate DEP intake of 0, 40/46, 197/222 or 1016/1150 mg/kg/day for F0/ F1 males and 0, 51/56, 255/267 or 1297/1375 mg/kg/ day for F0/F1 females, respectively) for two successive generations. Adult (F0, F1) and postnatal day 26 (F1, F2) autopsies were conducted.
In F0 and F1 parental males and females, the deaths found in this study were not considered due to DEP-treatment, because the incidence was very low and in line with earlier toxicology studies. A few changes in body weight gain and food consumption were observed in F0 and F1 parental rats. The changes in food consumption were not accompanied by changes in body weight, were transient and inconsistent across generations and thus seem unlikely to reflect toxic effects of DEP.
The gestation length was shortened in F1 females in the 15000 ppm group. This change was not considered attributable to DEP-treatment because the value actually fell within the normal range for this strain of rat (Masuda et al., 2000) .
Testicular toxicity indicated by testicular atrophy and decreased testicular weights in rats has been reported following administration of DEHP or DBP, other phthalate esters (Gray and Butterworth, 1980; Park et al., 2002; Zhang et al., 2004) . No such changes were observed on treatment with DEP. In this study, incidences of abnormal sperm, including tailless sperm, were significantly increased in F0 males in the 3000 ppm group and in F1 males in the 3000 and 15000 ppm groups. However, these changes were not considered toxicologically significant because of the lack of effects on reproductive parameters such as copulation and fertility indices, sperm counts and sperm motility, and no histopathological findings for the testis and epididymis in these groups.
With respect to sexual development, vaginal opening was significantly delayed in F1 females in the 15000 ppm group as compared with the control group. Maternal exposure to xenoestrogens such as ethinylestradiol and diethylstilbestrol is known to accelerate vaginal opening in rats and mice (Masutomi et al., 2004; Nikaido et al., 2004; Thigpen et al., 2003) . On the other hand, delay in vaginal opening was observed in the litters receiving milk from the herbicide atrazineexposed rat dams (Rayner et al., 2004) . In this study, there was no significant difference in the body weights at vaginal opening and in the reproductive performance. Considering the significant decrease in uterine weight of F1 weanlings in the 15000 ppm group, the possibility that the delay in vaginal opening was related to the test substance treatment remains.
Absolute and/or relative liver weights of F0 and F1 males and females were significantly increased only in the 15000 ppm group. An increase in kidney weights was also observed in F1 females. However, the increase in liver weights was considered a generally biological reaction to exogenous xenobiotics, and the other change was considered less important toxicologically because it was not consistent across generations and there were no associated histopathological changes. In the 15000 group, absolute adrenal gland and epididymis weights in F0 males were significantly decreased. In the preliminary study, decrease in prostate weight as well as an increase in liver weight was observed, which was considered attributable partly to enhanced activities of steroid-metabolic enzymes in the liver. Significant increases in the contents of CYP4A1 and CYP3A2 were noted in the 15000 ppm group. It has been reported that phthalate esters belong to the peroxisome proliferator class of compounds (Bell and Elcombe, 1991; Okita and Okita, 1992) and that the CYP4A subfamily is induced by peroxisome proliferators (Okita and Okita, 1992) . Moreover, lipid and enzyme levels in the liver and serum have been reported to be altered by DEP-treatment in rats (Sonde et al., 2000) . The observed increase in CYP4A1 suggests that DEP has a capacity to induce peroxisomes. On the other hand, CYP3A levels in liver microsomes of male Wistar rats were reported to be increased by exposure to phenobarbital or dexamethasone, which are suggested to be involved in steroid metabolism (Peng and Lin, 2002) . The CYP3A subfamily hydroxylates both testosterone and progesterone at the 6β-position (Niwa et al., 1998) . In this study, the levels of serum testosterone were significantly decreased in the 3000 and 15000 ppm groups, indicating an increase in metabolism of testosterone. Testosterone is known to play an important role at testicular development in fetuses (Sharpe, 2001 ) and spermatogenesis in the testis in adults (Yamada and Miyaji, 1979) , but the reduction in testosterone levels was here not considered an adverse effect, because the degree of reduction was too Vol. 30 Special Issue slight to affect the reproductive capacity to produce the progeny and the extent of reduction in the 3000 ppm group was larger than that in the 15000 ppm group.
It has been reported that other phthalate esters such as BBP, DEHP and DBP cause decreases in AGD and increases in the incidence of undescended testes in rats (Ema and Miyawaki, 2002; Moore et al., 2001; Zhang et al., 2004) . However, no such changes were observed in this study. The basic chemical structure of phthalate esters has been considered responsible for the antiandrogenic activity. Gray et al. (2000) expected that phthalate esters with ester side chains four to six carbons in length in the ortho configuration, such as DEHP and BBP, would be antiandrogenic in utero, while DEP (C2-ortho position) would be inactive. Before weaning, a suppression of body weight gains, accompanied by retardation in physical development evidenced by pinna detachment and eye opening, was here found in F1 and F2 pups of both sexes at 15000 ppm. In this group, absolute and relative thymus weights in both sexes of the F1 and F2 weanlings and absolute and relative spleen weights in F2 males were significantly decreased, suggesting that the immune system might have been affected by DEP-treatment. These findings suggest that DEP indeed influences the development of offspring of rats given DEP pre-and postnatally at high dose. Although changes in weights of the brain, kidneys, thyroid glands, pituitary gland and seminal vesicles in F1 and F2 weanlings were observed, these were most likely secondary to the reduction in terminal body weights.
In conclusion, from the results of dietary administration of diethyl phthalate to rats through two successive generations, the no-observed-adverse-effect level (NOAEL) under the conditions of the present study for the general toxicity and reproductive performance in parental animals is considered to be 15000 ppm because no adverse effects were observed on systemic and reproductive parameters at dose levels up to 15000 ppm. For development and growth of pups, the NOAEL is 3000 ppm because body weight gain before weaning was inhibited at 15000 ppm.
